Boston Financial Management’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-15,150
Closed -$391K 196
2015
Q3
$391K Sell
15,150
-1,000
-6% -$25.8K 0.06% 168
2015
Q2
$400K Hold
16,150
0.05% 171
2015
Q1
$407K Buy
16,150
+300
+2% +$7.56K 0.05% 170
2014
Q4
$372K Buy
15,850
+500
+3% +$11.7K 0.05% 174
2014
Q3
$350K Hold
15,350
0.05% 174
2014
Q2
$375K Sell
15,350
-1,875
-11% -$45.8K 0.05% 175
2014
Q1
$363K Hold
17,225
0.05% 172
2013
Q4
$410K Hold
17,225
0.06% 167
2013
Q3
$369K Sell
17,225
-9,000
-34% -$193K 0.06% 172
2013
Q2
$522K Buy
+26,225
New +$522K 0.08% 156

Other funds holding QGENF

Boston Financial Management's QGENF Position: Q4 2015 in Review

Boston Financial Management sold out of QIAGEN NV (QGENF) in Q4 2015, closing a stake of 15,150 shares — an estimated $391K sold.

Boston Financial Management first reported a position in QGENF in Q2 2013 and held it in 10 quarters. The position peaked at $522K in Q2 2013. 191 funds tracked by Wall St. Rank hold QGENF as of Q4 2015.

  • Boston Financial Management reported no remaining QIAGEN NV position as of Q4 2015 after selling out during the quarter.
  • Boston Financial Management sold 15,150 QIAGEN NV shares in Q4 2015, an estimated $391K.
  • Boston Financial Management first reported a position in QIAGEN NV in Q2 2013 and held it in 10 quarters.
  • Boston Financial Management's QIAGEN NV position peaked at $522K in Q2 2013.
  • 191 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2015.

Based on Boston Financial Management's 13F filing for Q4 2015, filed 2 Feb 2016.